WTR Biotech Spotlight

Current State of Biotech, Market Pressure Points, Obesity and PD-1/VEGF

Joe Brunetto Season 1 Episode 6

Tim Gerdeman and Do Kim discuss the current state of biotech, what brought us here, and how the rest of year may look for the group. They also review recent market-shaping events in the obesity space and progress of the Keytruda-busting PD-1/VEGF bispecifics.